[go: up one dir, main page]

WO2004015390A3 - Proteines cibles du cancer du poumon et utilisations associees - Google Patents

Proteines cibles du cancer du poumon et utilisations associees Download PDF

Info

Publication number
WO2004015390A3
WO2004015390A3 PCT/US2003/024698 US0324698W WO2004015390A3 WO 2004015390 A3 WO2004015390 A3 WO 2004015390A3 US 0324698 W US0324698 W US 0324698W WO 2004015390 A3 WO2004015390 A3 WO 2004015390A3
Authority
WO
WIPO (PCT)
Prior art keywords
lung cancer
proteins
target proteins
cancer target
provides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/024698
Other languages
English (en)
Other versions
WO2004015390A2 (fr
Inventor
Stephen Hoffman
Ruobing Wang
Gangadharan Subramanian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Biosystems Inc
Original Assignee
Applera Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applera Corp filed Critical Applera Corp
Priority to AU2003258134A priority Critical patent/AU2003258134A1/en
Publication of WO2004015390A2 publication Critical patent/WO2004015390A2/fr
Anticipated expiration legal-status Critical
Publication of WO2004015390A3 publication Critical patent/WO2004015390A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G01N33/5752—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne cinq protéines cibles du cancer du poumon qui sont exprimées de manière différentielle dans des cellules ou des tissus du cancer du poumon. L'invention concerne également une méthode de détection du cancer du poumon. L'invention concerne en outre un vaccin de prévention et de traitement du cancer du poumon. Ce vaccin comprend des peptides immunogènes dérivés desdites cinq protéines et analogues de celles-ci. L'invention concerne enfin des anticorps qui ciblent de manière spécifique les protéines du cancer du poumon, et leur utilisation diagnostique et thérapeutique.
PCT/US2003/024698 2002-08-09 2003-08-08 Proteines cibles du cancer du poumon et utilisations associees Ceased WO2004015390A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003258134A AU2003258134A1 (en) 2002-08-09 2003-08-08 Lung cancer target proteins and use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40205702P 2002-08-09 2002-08-09
US60/402,057 2002-08-09

Publications (2)

Publication Number Publication Date
WO2004015390A2 WO2004015390A2 (fr) 2004-02-19
WO2004015390A3 true WO2004015390A3 (fr) 2007-12-13

Family

ID=31715780

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/024698 Ceased WO2004015390A2 (fr) 2002-08-09 2003-08-08 Proteines cibles du cancer du poumon et utilisations associees

Country Status (2)

Country Link
AU (1) AU2003258134A1 (fr)
WO (1) WO2004015390A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004026135A1 (de) * 2004-05-25 2006-01-05 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide
PT2172211E (pt) 2008-10-01 2015-03-09 Immatics Biotechnologies Gmbh Composição de peptídeos associados a tumores e vacina anti -cancro relacionada para o tratamento de glioblastoma (gbm) e outros tipos de câncer
GB0904355D0 (en) * 2009-03-13 2009-04-29 Imp Innovations Ltd Biological materials and uses thereof
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520568D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd Peptides
CN113164548A (zh) * 2018-11-07 2021-07-23 富力卡姆股份公司 用于治疗糖尿病的肽片段

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6147187A (en) * 1994-03-24 2000-11-14 Ludwig Institute For Cancer Research Isolated tumor rejection antigen precursor mage-2 derived peptides and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6147187A (en) * 1994-03-24 2000-11-14 Ludwig Institute For Cancer Research Isolated tumor rejection antigen precursor mage-2 derived peptides and uses thereof

Also Published As

Publication number Publication date
AU2003258134A1 (en) 2004-02-25
AU2003258134A8 (en) 2004-02-25
WO2004015390A2 (fr) 2004-02-19

Similar Documents

Publication Publication Date Title
WO2000061612A3 (fr) Composes et procedes de therapie et de diagnostic du cancer du poumon
WO1999047674A3 (fr) Composes et methodes therapeutiques et diagnostiques du cancer du poumon
NZ516381A (en) Lung tumor proteins in the therapy and diagnosis of lung cancer
WO1999038973A3 (fr) Composes destines au diagnostic et a la therapie du cancer du poumon et procedes d'utilisation associes
WO2004046342A3 (fr) Nouvelles cibles geniques et ligands se liant a ces cibles dans le traitement et le diagnostic de carcinomes
WO2003086308A3 (fr) Compositions et procedes pour le diagnostic et le traitement de l'infection du virus de l'herpes simplex
AU2003242305A1 (en) Hla-a24-restricted cancer antigen peptide
WO2002057741A3 (fr) Anticorps monoclonaux et antigenes de surface pour la detection et le traitement du cancer a petites cellules (sclc)
WO2004047863A3 (fr) Produits geniques exprimes de maniere differentielle dans des tumeurs et leur utilisation
WO2004067023A3 (fr) Peptides derives de la survivine et leur utilisation
WO1997025426A3 (fr) Compositions et procedes pour le traitement et le diagnostic du cancer du sein
WO1999033869A3 (fr) Composes destines a l'immunotherapie et au diagnostic du cancer du sein, et leur mode d'utilisation
WO2005049073A3 (fr) Proteines appartenant a la famille bcl-2, fragments associes, et utilisation therapeutique de ces proteines et fragments sur des patients atteints du cancer
AU2002319867A1 (en) Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets
AU2003256912A1 (en) Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines
WO1998045328A3 (fr) Compositions therapeutiques et diagnostiques du carcinome mammaire et methodes afferentes
WO2003016464A3 (fr) Sequences d'oligosaccharides specifiques pour le cancer et leur utilisation
WO2000061756A3 (fr) Composes pour l'immunotherapie et le diagnostic du cancer du sein et procedes d'utilisation
WO2002077176A3 (fr) Proteines presentant une expression aberrante dans des tumeurs microdissequees capturees au laser
EP1297147B8 (fr) Compositions pour le diagnostic et le traitement de l'infection du virus de l'herpes
WO2004015390A3 (fr) Proteines cibles du cancer du poumon et utilisations associees
WO2006023598A3 (fr) Peptides restreints par mhc classe ii derives d'antigenes specifiques a la prostate et leur utilisation dans des vaccins destines a traiter ou a prevenir le cancer de la prostate
WO2006137938A3 (fr) Fragments d'anticorps assurant la protection contre l'infection par des pathogenes, methodes d'utilisation de ces derniers
WO2005123760A3 (fr) Traitement du cancer
WO2000061753A3 (fr) Compositions et methodes de depistage et de traitement du cancer du sein

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP